Skip to main content

Table 2 Univariate survival analysis

From: Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

 

DFS

OS

 

% events

Mean survival, years (SE)

p

% events

Mean survival, years (SE)

p

GCDFP-15

     

0.044

Negative

30.3

5.85 (0.24)

 

19.3

7.07 (0.23)

Positive

25.1

6.67 (0.30)

0.052

13.9

7.75 (0.27)

HR

     

0.013

Negative

35.6

5.53 (0.36)

 

23.3

6.75 (0.34)

Positive

25.0

6.48 (0.23)

0.004

19.3

7.67 (0.34)

HER2

     

0.686

Negative

26.3

6.31 (0.22)

 

16.0

7.46 (0.21)

Positive

37.0

5.64 (0.40)

0.114

22.3

7.06 (0.24)

Biological tumor types

     

0.084

HR+/HER2-

23.2

6.61 (0.25)

 

13.7

7.71 (0.24)

HR+/HER2+

33.8

5.86 (0.52)

 

16.9

7.45 (0.43)

HR-/HER2+

43.6

4.98 (0.60)

 

30.8

6.23 (0.53)

HR-/HER2-

33.3

5.59 (0.42)

0.011

21.1

6.86 (0.41)

Age

     

0.046

< 50 years

24.9

6.48 (0.28)

 

12.8

7.79 (0.25)

> = 50 years

31.0

5.93 (0.26)

0.120

20.8

7.06 (0.24)

Histological type

     

0.915

Ductal/others

28.8

6.15 (0.20)

 

17.2

7.40 (0.19)

Lobular

10.0

6.42 (0.55)

0.309

17.4

6.82 (0.55)

grading

     

0.043

G1-2

26.4

6.42 (0.22)

 

16.1

7.54 (0.20)

G3

34.6

5.35 (0.41)

0.005

20.8

6.70 (0.40)

cT

     

0.001

cT1-2

20.8

6.90 (0.24)

 

12.4

7.88 (0.22)

cT3-4

43.9

4.93 (0.31)

<0.0001

26.7

6.65 (0.31)

cN

     

<0.0001

cN0

22.4

6.91 (0.28)

 

11.4

8.12 (0.24)

cN+

33.9

5.56 (0.26)

<0.0001

22.5

6.75 (0.25)

  1. DFS: disease-free survival.
  2. OS: overall survival.
  3. SE: standard error.